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Abstract
Background: Polymorphisms in the vitamin D receptor (VDR) gene have been studied in immune-related
disorders either as independent contributors or in combination with vitamin D concentration. Vitamin D and
VDR have been independently linked to asthma susceptibility. We investigated whether VDR variants were
associated independently or in relation to vitamin D levels with asthma in Cypriot adolescents.
Methods: We studied 190 current wheezers, 69 of which were categorized as active asthmatics and 671 healthy
controls. We determined three VDR genotypes (BsmI, TaqI, ApaI) and measured serum 25(OH)D levels. Logistic
regression and stratified analyses by the presence of hypovitaminosis D (≤20 ng/ml) were used to evaluate the
association of the VDR variants with asthma.
Results: The distribution of TaqI genotypes was significantly different between controls and current wheezers
(p = 0.030) or active asthmatics (p = 0.014). The tt genotype was over-represented in wheezers (19.2 %) and
asthmatics (21.3 %) compared to respective controls (12.9 %). No difference was observed between controls,
current wheezers and active asthmatics in the genotypic distribution of BsmI and ApaI polymorphic sites. After
stratification by the presence of hypovitaminosis D, a significant association was detected between tt genotype
of TaqI polymorphism with wheezing (OR: 1.97, 95 % CI: 1.12, 3.46) and asthma (OR: 2.37, 95CI%: 1.02, 5.52) only
in those with normal vitamin D levels (>20 ng/ml) but not in subjects with low vitamin D.
Conclusions: The minor TaqI genotype of VDR is associated with asthma in Cypriot adolescents. This
polymorphism may contribute to asthma susceptibility primarily under conditions of normal vitamin D levels
(>20 ng/ml).
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Background
The role of vitamin D in immune-related disorders has
been investigated extensively in the last years. In particu-
lar, epidemiological studies have shown a positive link be-
tween vitamin D deficiency and asthma susceptibility or
asthma characteristics among asthmatic children [1–8].
Nevertheless, several other studies have not replicated
theses associations [9–13].
Vitamin D Receptor (VDR) is the mediator of the vita-
min D pleiotropic biological actions. The 1,25(OH)2D-
VDR complex acts as a nuclear transcription factor which
exerts its effects via binding to specific VDR-binding sites
of the responding genes, the vitamin D responsive ele-
ments [14]. More than 900 genes may be transcribed by
VDR [15–17] whereas the ubiquitous expression of the
receptor in a wide variety of human tissues potentiates the
role of vitamin D in functions beyond the classical skeletal
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effects [18, 19]. The role of the VDR locus in the develop-
ment of asthma and allergy is still under investigation.
The activation of the receptor contributes to immune
responses via regulation of Th1/Th2 cytokines balance
and reduces production of Th2 cytokines (IL-5, IL-10)
[20–23]. Furthermore, VDR expression in dendritic cells
and activated macrophages has been demonstrated to
restrict the inflammatory response and attenuate the se-
verity of allergic phenotypes [24–27]. Additionally to the
immuno-modulatory impact, vitamin D has been dem-
onstrated to affect lung structure and function, while its
expression has been identified in airway epithelium [28]
and bronchial smooth muscle cells [11, 29].
Several studies have examined the association between
genetic variants of the VDR and asthmatic populations
in different ethnic groups [30–36]. Among the most
studied single nucleotide polymorphisms (SNP) are
those located in the last intron, (BsmI and ApaI), and in
the last exon (TaqI) of the gene. These genetic variations
may influence VDR’s RNA stability and translation
efficiency and consequently the transcription of the tar-
get genes [37–39]. Two family-based association studies
conducted in North America populations and two case–
control studies, in Chinese Hans and Tunisian popula-
tions, showed significant association between one or
more of VDR polymorphisms with asthma [30–32, 34].
However, these findings were not replicated in Afro-
American [35] or German populations [40]. Most of
these studies examined VDR polymorphisms as inde-
pendent factors for asthma susceptibility. Interestingly,
a recent meta-analysis after concluding that TaqI and
BsmI contribute to asthma susceptibility, suggested that
this effect could be modified by environmental factors
such as levels of serum 25(OH)D [41]. Similar findings
have been reported for the associations of VDR poly-
morphisms with autoimmune disorders [42] and differ-
ent types of cancer [43–45].
In this study we aimed a) to examine the associations
of three well known genetic variants of the VDR gene
with wheezing and asthma in a cohort of adolescents in
Cyprus and b) to investigate the impact of these poly-




The participants of this study were selected from a
cohort of 3982 children who participated in two large
school-based health surveys in Cyprus. The first survey
in years 2001–2003 involved all children (n = 19,849) at-
tending the 6th form across all primary schools in
Cyprus and focused on nutrition and physical fitness.
This survey was followed by a second one in year 2007,
which recruited 3982 of those participated in the first
(20.1 %) and focused on respiratory health (International
Study of Asthma and Allergies in Childhood–ISAAC)
and risk factors for asthma [46]. In year 2008 when aged
16–18 years and in a case–control design, we invited all
those from the 3982 children who on the second survey
(ISAAC questionnaire) were current wheezers to partici-
pate in this study along with a triplicate number of
healthy controls. Current Wheezers were participants
who reported wheezing in the past 12 months (Current
Wheezers–CUW) and for the purpose of performing a
sensitivity analysis, the case definition was further
refined to Current Wheezing and Asthma (CUWA), if
there was also report of diagnosis of asthma ever. Con-
trols were selected amongst the 3982 adolescents that
did not report any wheezing or asthma ever (Never
Wheezers Never Asthmatics–NWNA). NWNA were se-
lected using a stratified random sampling approach in
order to increase the probability of selection of children
at the extremes of BMI change between childhood and
adolescence, in line with the scope of another study on
the relation of adiposity with asthma. Based on the
above selection criteria the group of controls consisted
of 671 NWNA and the group of patients of 190 CUW
subjects. Among the CUW patients, 69 were categorized
as active asthmatic forming the CUWA subgroup
(Fig. 1). All participants and their guardians provided
informed consent and the study was approved by the
National Bioethics Committee of Cyprus.
Measurements
Collected blood samples were centrifuged on site and
serum aliquots were stored at −80 °C until further use.
Subsequently, serum levels of 25(OH)D were measured
using the enzyme immune assay kit of the Immuno
diagnostics Systems Ltd, UK. The intra- and inter-assay
coefficients of variation were 12 %.
Atopic sensitization was assessed with skin prick tests
(SPT) to 8 common aeroallergens (Greer, USA), (Derp 1
& 2, cat, bahia, mugwort common, grasses, mold mix,
olive, weeds and negative (50 % glycerinated saline) and
positive (histamine, 1.0 mg/mL) controls) performed
and interpreted according to the GA2LEN recommen-
dations [47]. Lung function was assessed through meas-
urement of forced expiratory volume in 1 s (FEV1) and
forced vital capacity (FVC) with the help of a spirometer
(Vitallograph, UK) and values were expressed as percent
of the predicted for the child’s height, age and gender.
Genotyping
Genomic DNA was isolated from whole blood. We tested
three VDR polymorphisms which have been associated
with asthma or other pulmonary diseases in several stud-
ies among different populations: TaqI (rs731236), BsmI
(rs1544410) and Apa I (rs7975232). TaqI polymorphism is
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a synonymous site, a single base change T to C in codon
352 at the 3′ end of the gene. BsmI and ApaI variants are
located in the last intron of the gene resulting from a sin-
gle base change A to G and G to T respectively. TaqI and
ApaI genotypes were determined on a single 628-bp
polymerase chain reaction (PCR) fragment using primers
located within intron 8 and exon 9 (5′-CTAGGTCTGG
ATCCTAAATGCA-3′ and 5′-TTAGGTTGGACAGGA
GAGAGAA-3′). BsmI genotypes were determined on a
348 bp fragment using the primers 5′-CGGGGAGTATG
AAGGACAAA-3′ and 5′-CCATCTCTCAGGCTCC
AAAG-3′. Following amplification, the PCR products
were subjected to endonuclease digestion for 90 min at
65 °C for Taq I, 2 h at 25 °C for ApaI and 90 min at 65 °C
for BsmI. After gel electrophoresis of the restriction
products, the different genotypes were distinguished by
different fragment sizes. The presence of the restriction
site was presented with the lowercase allele (b, t, a) and
the absence with the uppercase (B, T, A). Thus, for TaqI,
the TT genotype resulted in fragments of 433 bp and
195, tt in three fragments of 232, 201 and 195 bp and Tt
in four fragments of 433, 232, 201 bp και 195 bp; for
BsmI, BB resulted in one fragment of 348 bp, bb in two
fragments of 242 and 106 bp, and Bb in all three frag-
ments; for ApaI, AA resulted in one fragment of 628 bp,
aa in two fragments of 477 and 151 bp, and Aa exhibited
all three fragments.
Among the analysed 861 samples, BsmI polymorphism
was not detected in 51 samples (11 CUW, 6 CUWA
and 40 controls), TaqI polymorphism was not detected
in 54 samples (13 CUW, 8 CUWA and 41 controls) and
similarly Apa I polymorphism was not detected in 52
samples (14 CUW, 8 CUWA and 38 controls) due to
technical difficulties. These polymorphisms were con-
sidered as missing values and were not included in stat-
istical analysis.
All 3 SNPs were tested for associations with asthmatic
status and atopic sensitization.
Statistical analysis
Participant characteristics of the two cases groups and
controls were compared using the chi square test and
t-test in the case of categorical and continuous vari-
ables respectively. Chi-square testing was used for
Hardy-Weinberg equilibrium determination. For the in-
vestigation of genotypic associations, odd ratios (OR)
Fig. 1 Course of the study: from the 19,849 participants (11–12 years) in Survey 1, a random sample of 3982 adolescents (15–17 years)
participated in Survey 2. All (n = 297) subjects from the 3982 sample, who reported wheezing in the last 12 months were invited to participate as
cases. A sample of 932 children with no diagnosis of asthma and no wheezing in the past 12 months were invited to participate as controls
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were reported for the allelic distribution in the study
groups. Furthermore, the effect of the homozygous
genotypes of the minor alleles was compared against
the effect of all other genotypes using binary logistic
regression analysis while adjusting for the presence of
hypovitaminosis D (≤20 ng/ml). This analysis was also per-
formed separately for participants with and without hypo-
vitaminosis (≤20 ng/ml) in order to assess the potential
interaction effect of vitamin D levels on the relationship of
genotypes and CUW or CUWA. Stratum specific ORs and
the significance level for interaction were reported. All stat-
istical analyses were performed with SPSS statistical pack-
age, version 20.0 (IBM, SPSS Inc., Chicago, IL).
Results
Study population characteristics
No difference in age and sex distribution was recorded
between CUW, CUWA and controls. The mean serum
25(OH)D level in the Control group was 22.9 ng/ml versus
22.94 ng/ml in CUW (p > 0.05) and 21.15 ng/ml in CUWA
(p = 0.017). As expected, SPT positivity at 41.4 and 52 %
among CUW and CUWA was significantly higher than the
25 % in Controls (p < 0.001; <0.001, respectively) (Table 1).
Allergic rhinitis was also much more frequent among
CUW (41.5 %) and CUWA (57.4 %) than in Controls
(18.4 %) (p < 0.001; <0.001, respectively) (Table 1). Main
spirometrric indices were not different between study
groups.
Associations of VDR genotypes with asthma
The genotypes of TaqI, BsmI and ApaI polymorphic sites
were in Hardy-Weinberg equilibrium in all study groups.
The VDR genetic variants were not associated with
25(OH)D levels in the total population or among con-
trols and patients when examined separately (Additional
file 1: Table S1). All SNPs were evaluated for associa-
tions with CUW and CUWA status (Table 2). The dis-
tribution of the three TaqI genotypic groups (TT, Tt, tt)
was significantly different between controls and CUW
(p = 0.030) (Table 2) or CUWA (p = 0.014) (Table 3).
Particularly, the tt genotype was over-represented in
CUW (19.2 %) and CUWA (21.3 %) compared to the
respective controls (12.9 %) (OR: 1.59 (95 % CI: 1.02,
2.50); OR: 1.80 (95 % CI: 0.93, 3.48), respectively) No
significant difference was observed between controls
and CUW or CUWA in the frequencies of the geno-
types BB/Bb/bb and AA/Aa/aa of the BsmI and ApaI
polymorphic sites respectively. No association was
found between the study groups in the genotypic distri-
bution when we examined the allelic distribution (pres-
ence or absence of the minor allele) (Tables 2 & 3).
TaqI interaction with vitamin D status
The only SNP that was found to be significantly associ-
ated with the asthmatic phenotypes, TaqI was separately
evaluated in participants with and without hypovitami-
nosis D (serum levels of 25(OH)D ≤20 ng/ml) in order
to examine the potential interaction effect of vitamin D
status on its association with CUW or CUWA. Al-
though p value (0.245) for interaction did not reach stat-
istical significance, we performed a stratified analysis
which indicated that the association of TaqI homozy-
gous minor genotype (tt) with CUW was particularly
pronounced among the subgroup of participants with
normal vitamin D [OR:1.97 (95 % CI:1.12–3.46)]. In
contrast, in subjects with low vitamin D the odds ratio
estimate [OR:1.13 (95 % CI:0.54–2.38)] was weaker and
not statistically significant, indicating a smaller contribu-
tion of this subgroup in the observed association
(Table 4). A similar result was obtained for the associ-
ation of genotype tt of TaqI with CUWA in the high
vitamin D stratum [OR:2.37 (95 % CI: 1.02–5.52)] as op-
posed to the low vitamin D stratum [OR:1.24 (95 % CI:
0.44–3.54)] (p-value for interaction = 0.348) (Table 5).
Discussion
In this case–control study of VDR gene variants among
Cypriot adolescents, we found that the TaqI homozygous





P value CUWA (Active Asthmatics)
(n = 69)
P value
Age (yrs)a 17.0 (15.9–18.0) 17.0 (16.0–18.1) 0.360 16.9 (15.9–18.1) 0.549
Sex (% male)b 40.5 % 43.1 % 0.517 43.5 % 0.626
Vitamin D levels (ng/ml)a 22.9 (10.9–35.9) 22.9 (10.5–23.8) 0.946 21.1 (8.8–30.81) 0.017
Sensitization (% positive)b 25.7 % 41.4 % <0.001 52.0 % <0.001
Rhinitis (% positive)b 18.4 % 41.5 <0.001 57.4 % <0.001
FVC (% predicted)a 103.8 (72.7–135.9) 104.9 (77.1–148.3) 0.531 105.6 (78.0–153.6) 0.484
FEV1 (% predicted)a 99.3 (69.6–125.3) 99.1 (72.9–130.5) 0.860 97.6 (62.0–125.6) 0.398
NWNA Never Wheezing Never Asthma, CUW Current Wheezing, CUWA Current Wheezing and Asthma
aMean and 95 % CI, Independent sample t test for equality of means (2-sited significance)
bPercentage, χ2 test (asymptomatic 2-sited significance)
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minor genotype was associated with wheezing and asthma.
Even though there was no significant statistical evidence
for effect modification in the TaqI-asthma association by
vitamin D status, the association appeared stronger among
those with higher vitamin D level. No other significant as-
sociation was detected in the distribution of genotypes and
alleles frequencies between asthmatics, wheezers and con-
trols for the BsmI and ApaI polymorphisms.
Our results on VDR polymorphisms associations with
asthma are partly in agreement with the findings of Poon
et al. in a family-based cohort of a French-Canadian
founder population where TaqI and BsmI polymorphisms
have been associated with asthma in children while ApaI
has not [32]. Raby et al. [31] tested a total of 7 loci in the
VDR gene in individuals from two different cohorts: the
Nurses’ Health study population and the Childhood
Asthma Management Program (CAMP) population. The
association between TaqI polymorphism and asthma in
the 582 pedigrees selected from the family based Nurses’
Health study population could not be replicated in the
case–control study of CAMP. A more recent case–con-
trol study performed by Maalmi et al. [34] showed a dif-
ferent distribution of genotype frequencies of VDR
variants (i.e. FokI, BsmI and TaqI) between asthmatic and
non-asthmatic Tunisian children aged 9 years. On the
other hand, three case–control studies conducted in the
Chinese Han population investigating the association of
genetic variants in the VDR with asthma susceptibility
have led to contradictory results [30, 36, 48]. The first
was conducted among 1090 individuals including 567
asthmatic patients and among all VDR polymorphisms
tested only the ApaI marker showed a significant
Table 2 Genotypic and allelic association analysis of VDR single-nucleotide polymorphisms between NWNA and CUW
SNP Genotypic association Allelic association
NWNA (n, %) CUW (n, %) χ2 P value NWNA (n, %) CUW (n, %) OR (95 % CI) P value
BsmI
BB 127 (20.1 %) 38 (21.2 %)
Bb 327 (51.8 %) 103 (57.5 %) B 581 (46 %) 179 (50 %)
bb 177 (28.1 %) 38 (21.2 %) 3.387 0.184 b 681 (54 %) 179 (50 %) 1.17 (0.93–1.48) 0.187
TaqI
TT 224 (35.6 %) 69 (39 %)
Tt 325 (51.6 %) 74 (41.8 %) T 773 (61.3 %) 212 (59.9 %)
tt 81 (12.9 %) 34 (19.2 %) 7.032 0.030 t 487 (38.7 %) 142 (40.1 %) 0.94 (0.74–1.20) 0.622
ApaI
AA 232 (36.7 %) 68 (38.6 %)
Aa 312 (49.3 %) 91 (51.7 %) A 776 (61.3 %) 227 (64.5 %)
aa 89 (14.1 %) 17 (9.7 %) 2.343 0.310 a 490 (38.7 %) 125 (35.5 %) 1.15 (0.90–1.47) 0.292
Table 3 Genotypic and allelic association analysis of VDR single-nucleotide polymorphisms between NWNA and CUWA
SNP Genotypic association Allelic association
NWNA (n, %) CUWA (n, %) χ2 P value NWNA (n, %) CUWA (n, %) OR (95 % CI) P value
BsmI
BB 127 (20.1 %) 11 (17.5 %)
Bb 327 (51.8 %) 32 (50.8 %) B 581 (46 %) 54 (42.8 %)
bb 177 (28.1 %) 20 (31.7 %) 0.492 0.782 b 681 (54 %) 72 (57.2 %) 0.88 (0.61–1.27) 0.513
TaqI
TT 224 (35.6 %) 28 (45.9 %)
Tt 325 (51.6 %) 20 (32.8 %) T 773 (61.3 %) 76 (62.3 %)
tt 81 (12.9 %) 13 (21.3 %) 8.492 0.014 t 487 (38.7 %) 46 (37.7 %) 1.04 (0.71–1.53) 0.922
ApaI
AA 232 (36.7 %) 19 (31.1 %)
Aa 312 (49.3 %) 34 (55.7 %) A 776 (61.3 %) 72 (59 %)
aa 89 (14.1 %) 8 (13.1 %) 0.966 0.617 a 490 (38.7 %) 50 (41 %) 0.91 (0.62–1.33) 0.628
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association with asthma [30]. The second study has re-
ported no significant differences in the genotype and
allele frequencies of FokI and BsmI polymorphisms of
VDR gene between 101 asthma patients and 206 healthy
controls [36]. In the third study all 8 exons of VDR have
been sequenced in 467 cases and 288 unrelated healthy
controls and failed to find any association between VDR
genetic variants and asthma [48].
In a small pilot study conducted among African
Americans, Pillai et al. did not find any association of
VDR genetic variants with asthma susceptibility [35];
however, within the asthma cohort, six polymorphisms
in the VDR gene were significantly associated with
quantitative asthma characteristics such as lower base-
line spirometric measures and increased IgE levels.
The overall picture of conflicting findings between
studies may be due to the phenotypical diversity of
asthma and allergy and the different study designs, which
assessed different outcomes such as asthma, wheezing,
respiratory infections, atopic dermatitis or allergic rhin-
itis. In addition to the diversity and imprecision in the
definition of outcomes, some of the studies lacked stat-
istical power for revealing any associations with specific
outcomes. Furthermore, polymorphisms are subject to
ethnic variations and geographical differences and the
interaction between VDR gene variants with environ-
mental conditions may also differ among populations.
The three tested polymorphisms although are non-
functional, they are considered to be linked with other
functional polymorphisms and thus participate in a
more complex gene network enhancing or inhibiting
the expression of VDR target genes [37]. Vitamin D
metabolites concentrations may be influenced by VDR
polymorphisms as many of the VDR targets are key
regulators of vitamin D pathway. Morrison et al. [38]
suggested that BsmI and TaqI VDR polymorphisms de-
fine differential transcriptional VDR activity or mRNA
stability in vitro. In particular, the BB and tt genotypes
have been associated with decreased VDR function and
elevated levels of 1,25(OH)2D3.
Although, the optimal level of 25(OH)D [49–51], es-
pecially for the non-classical actions of vitamin D, has
not yet been defined, low levels of vitamin D are associ-
ated with higher risk of having asthma [1–7]. Even
though in our population vitamin D levels were signifi-
cantly lower in asthmatics than in healthy adolescents
(p < 0.05) there was no association between VDR gen-
etic variants and 25(OH)D levels in the total population
or among controls and patients when examined separ-
ately. In stratified analyses based on vitamin D defi-
ciency/non-deficiency status, we observed that the tt
genotype of the Taq I polymorphism was more frequent
in wheezers and asthmatics with normal vitamin D
levels compared to the respective subgroup of controls.
These findings suggest that altered VDR signaling is be-
coming important mediator of the effects of vitamin D
on asthmatic status in the presence of adequate vitamin
D levels whereas in the case of vitamin D deficiency the
functionality of VDR compared to the overall effect of
vitamin D deficiency on asthma risk is not perhaps so
significant. Previous studies have reported an inter-
action between genotype and disease only in conditions
of higher or lower exposure to a specific environmental
factor, but findings are still inconsistent [52, 53]. Re-
garding VDR polymorphisms, stronger associations of
advanced prostate cancer have been shown with VDR
genotypes ff and AA of the polymorphisms FokI and
CDX-2 respectively, in the presence of adequate levels
of ultraviolet radiation [54]. In contrast to our findings,
TaqI tt genotype was found to have no or a protective
effect for prostate cancer under adequate levels of sun
exposure [54, 55].
There are a number of limitations. The use of self-
reported questionnaire data to define the study outcomes
is not as accurate as the use of clinical parameters. How-
ever, most of the previously published studies have also
Table 4 Detailed genotypic analysis between NWNA and CUW and between NWNA and CUWA
SNP NWNA (n, %) CUW (n, %) ORa NWNA (n, %) CUWA (n, %) ORa
BsmI
BB/Bb 454 (71.9 %) 141 (78.8 %) 454 (71.9 %) 43 (68.3 %)
bb 177 (28.1 %) 38 (21.2 %) 0.70 (0.47–1.04) 177 (28.1 %) 20 (31.7 %) 1.19 (0.68–2.09)
TaqI
TT/Tt 549 (87.1 %) 143 (80.8 %) 549 (87.1 %) 48 (78.7 %)
tt 81 (12.9 %) 34 (19.2 %) 1.59 (1.02–2.50) 81 (12.9 %) 13 (21.3 %) 1.80 (0.93–3.48)
ApaI
AA/Aa 544 (85.9 %) 159 (90.3 %) 544 (85.9 %) 53 (86.9 %)
aa 89 (14.1 %) 17 (9.7 %) 0.66 (0.38–1.14) 89 (14.1 %) 8 (13.1 %) 0.86 (0.41–1.94)
aAdjusted for vitamin deficiency status (<20 ng/ml)
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Table 5 Stratified genotypic analysis of TaqI among NWNA and CUW and NWNA and CUWA
Whole population Low vitamin D stratum (≤20 ng/ml) High vitamin D stratum (>20 ng/ml) P value for
interactionSNP TaqI (n, %) (n, %) ORa (n, %) (n, %) ORa (n, %) (n, %) ORa
NWNA CUW NWNA CUW NWNA CUW
TT/Tt 549 (87.1 %) 143 (80.8 %) 183 (82.4 %) 46 (80.7 %) 357 (89.5 %) 96 (81.4 %)
tt 81 (12.9 %) 34 (19.2 %) 1.59 (1.02–2.50) 39 (17.6 %) 11 (19.3 %) 1.13 (0.54–2.38) 42 (10.5 %) 22 (18.6 %) 1.97 (1.12–3.46) 0.245
NWNA CUWA NWNA CUWA NWNA CUWA
TT/Tt 549 (87.1 %) 48 (78.7 %) 183 (82.4 %) 19 (79.2 %) 357 (89.5 %) 29 (78.4 %)
tt 81 (12.9 %) 13 (21.3 %) 1.80 (0.93–3.48) 39 (17.6 %) 5 (20.8 %) 1.24 (0.44–3.54) 42 (10.5 %) 8 (21.6 %) 2.37 (1.02–5.52) 0.348













used epidemiological definitions for asthma. In this study
we initially used the looser case definition of Current
Wheezers (CUW–report of wheezing in the past
12 months) and then we performed a sensitivity ana-
lysis, where the case definition was further refined with
the combination of Current Wheezing and report of
Asthma (CUWA). The estimates we found for TaqI
with the stricter asthma definition were in the same
direction and magnitude with those found with the
looser definition although there was not always statis-
tical significance due to the smaller sample size. Al-
though misclassification in defining the disease status is
more likely in epidemiological definitions of asthma, we
do not think that this could have been influenced by
the type of VDR genetic variants of the subjects and
thus confound the recovered associations. If anything,
the noise in the data accompanying the epidemiological
definition of asthma would have pushed the signifi-
cance of our estimates towards the null. Although we
adjusted the associations of VDR genotypes with
asthma for vitamin D status, we cannot exclude the
presence of residual confounding by variables not mea-
sured with our questionnaires.
Conclusions
In conclusion, we found an association of the minor TaqI
genotype with asthma in Cypriot teenagers. We also ob-
served that the minor TaqI genotype is probably not an
independent factor for asthma susceptibility but it
assumes its mediating role in the association of the dis-
ease under certain environmental conditions such as nor-
mal vitamin D concentrations. Further studies are needed
to confirm this finding in larger populations and reveal
the functional mechanisms implicated in the interaction
of vitamin D with asthma and VDR genotype expression.
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